ProfileGDS5822 / ILMN_2571502
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 34% 14% 53% 7% 38% 12% 15% 24% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.634
GSM1276600PDAC Late Ablation Control 21314
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 12153
GSM1276603PDAC Late Ablation 27.17
GSM1276604PDAC Late Ablation 318.638
GSM1303940PDAC Late Ablation_anti-CTLA4 110.412
GSM1303941PDAC Late Ablation_anti-CTLA4 28.915
GSM1303942PDAC Late Ablation_anti-CTLA4 312.124